Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06475183 · ClinicalTrials.gov registry record · NA
Probiotic Chocolate Study in Multiple Sclerosis
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT06475183 is a NA study that has completed, run by Columbia University. The registered enrollment target is 92 participants.
The verdict
NCT06475183, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The goal of this study is to assess the effects of probiotics on persons with multiple sclerosis (MS), persons at higher genetic risk for MS (first degree family members of persons with MS), and healthy controls. Participants will be asked to consume probiotic containing chocolates (Bouchard Belgian Dark Chocolate Probiotic Napolitains containing 10 billion CFUs of bifidobacterium longum per day) for 6 weeks. Participants will undergo blood draws before and after the 6 weeks of probiotic containing chocolate and microbial metabolites and immune markers will be compared before and after the probiotics, as well as between groups.
Interventions
- DIETARY_SUPPLEMENT Bouchard Belgian Dark Chocolate Probiotic Napolitains, containing bifidobacterium longum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2024-12-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06475183
The ClinicalTrials.gov registry entry for NCT06475183 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bouchard Belgian Dark Chocolate Probiotic Napolitains, containing bifidobacterium longum is the first listed.
NCT06475183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06475183 about?
NCT06475183 is a clinical study titled "Probiotic Chocolate Study in Multiple Sclerosis". The goal of this study is to assess the effects of probiotics on persons with multiple sclerosis (MS), persons at higher genetic risk for MS (first degree family members of persons with MS), and healthy controls. Participants will be asked to consume probiotic containing chocolates (Bouchard Belgian...
What is the current status of trial NCT06475183?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2024-06-01. Estimated completion is 2024-12-09.
What interventions are being tested in trial NCT06475183?
The interventions under investigation include: Bouchard Belgian Dark Chocolate Probiotic Napolitains, containing bifidobacterium longum (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06475183?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.